![]() |
16th International AIDS ConferenceToronto, Canada - August 13 - 18, 2006 |
ASSESSING THE ROLE OF TREATMENT SUPPORT SPECIALIST (TSS) IN PEPFAR ADHERENCE PROGRAM IN NIGERIA
Int Conf AIDS. 2006 Aug 13-18;16 Abstract No. ThLB0505
H. Ibrahim1, J. Kohler1, S. Gurumdi1, A. Habib1, P. Dakum2, J. Farley2, W. Blattner3, M. Eng3
1Institute of Human Virology, Clinical Services, Abuja, Nigeria, 2Institute of Human Virology, Abuja, Nigeria, 3Institute of Human Virology, University of Maryland, Boltimore, United States
ISSUES: Inadequate adherence may result in inadequate drug concentrations, incomplete inhibition of HIV replication and may accelerate viral resistance. Drug resistance is a cause for concern in Nigeria, particularly because of the few options for second- and third-line therapy. A patient who fails on his or her first regimen due to drug resistance will have few treatment options left. Non adherence is one of the major factors of drug resistance.
DESCRIPTION: This is an observational study of the adherence activity at one of the PEPFAR- ACTION project sites in the North. Prior to the ACTION project, adherence services for HIV patients on medication did not exist, though the Government of Nigeria started its ART program in 2000 in hospitals across the states.
According to ACTION, if a physician places a patient on ARVs, the adherence counselor prepares the patient to develop a treatment plan. An increasing number of patients’ get access to care and treatment at ACTION sites, and many of these patients come from the local/neighboring communities. Adherence requires continual attention and monitoring, requiring exploration of additional avenues to assist with patients’ medication adherence.
Non clinicians do provide adherence support to overcome possible barriers. These are HIV+ peers referred to as Treatment Support Specialists who can relate to patients in a different way from formal health-care workers’ style. They counsel patients both in the facility and at home.
LESSONS LEARNED: This approach has a positive impact on patients’ adherence efforts because of increased treatment literacy, which is evident by the less time, spent with adherence counselors especially those visited and assisted at home by TSS. Family members are motivated to give social support to clients thereby reducing the problems of stigmatization.
RECOMMENDATIONS:
Download PDF of this abstract.
2006-08-13
ThLB0505
Copyright © 2006 - International AIDS Society (IAS). All information and content relating to the abstracts from the 16th International AIDS Conference, such as text, graphics, logos, button icons, images, audio clips, and software is protected by copyright. Permission is hereby granted for the non-commercial use or reproduction of the information on this web site, provided that the use of such information is accompanied by an acknowledgement that IAS is the source of the information and the name of the author of the article.
AEGiS is a 501c(3) not-for-profit organization made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, GlaxoSmithKline, the National Library of Medicine, Roche / Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 2006. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2006. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. Permission is hereby granted for the non-commercial use or reproduction of the information herein, provided that the use of such information is accompanied by an acknowledgement that IAS is the source of the information and the name of the author of the article.